Tuberculosis in solid-organ transplant recipients: disease characteristics and outcomes in the current era.

By Aguado García, José María | García Reyne, Ana. Progress in transplantation (Aliso Viejo, Calif.), 2014 . 24(1):37-43. , Formato Vancouver: Sun HY, Muñoz P, Torre Cisneros J, Aguado JM, Lattes R, Montejo M et al. Tuberculosis in solid-organ transplant recipients: disease characteristics and outcomes in the current era. Prog Transplant. 2014 Mar;24(1):37-43.

Place Hold on Tuberculosis in solid-organ transplant recipients: disease characteristics and outcomes in the current era.

Bone loss after heart transplant: effect of alendronate, etidronate, calcitonin, and calcium plus vitamin D3.

By Cruz Bértolo, Javier de la | Delgado Jiménez, Juan Francisco | Gómez Sánchez, Miguel Ángel | Guadalix Iglesias, Sonsoles | Hawkins Carranza, Federico Gustavo | Lora Pablos, David | Martínez Díaz-Guerra, Guillermo | Vara Paniagua, Jesús María. Progress in Transplantation , 2012 . 22(3):237-43. , Formato Vancouver: Gilfraguas L, Guadalix S, Martínez G, Jodar E, Vara J, Gómez-Sánchez MA, Delgado J, De La Cruz J, Lora D, Hawkins F. Bone loss after heart transplant: effect of alendronate, etidronate, calcitonin, and calcium plus vitamin D3. Prog Transplant. 2012 Sep;22(3):237-43.

Place Hold on Bone loss after heart transplant: effect of alendronate, etidronate, calcitonin, and calcium plus vitamin D3.

Search for 'Provider:Progress in Transplantation ,'

Tuberculosis in solid-organ transplant recipients: disease characteristics and outcomes in the current era.

Bone loss after heart transplant: effect of alendronate, etidronate, calcitonin, and calcium plus vitamin D3.